logo_isd
聯絡我們English繁體中文簡體中文
logo_isdlogo_isd

Microbio

MENUMENU
MENUMENU
  • ABOUT US
    • ABOUT
    • CORE VALUE
    • COMPANY STRATEGY
    • ESTABLISHMENT HISTORY
    • CORPORATE LOGO
    • 經營團隊en
    • GOVERNANCE STRUCTURE
  • R & D
    • new drug development
    • new drug development
      • MS-20
      • herbiron
      • ACADEMIC ARTICLE
    • MS-20 Zone
      • PRODUCT INFORMATION
      • RETAIL CHAIN
      • CLINICAL EFFICACY
      • FAQ
      • CONTACT US
    • Health Education Area
      • MS-20 (Health Education Area )
      • HERBIRON (HEALTH EDUCATION AREA )
  • SYMBIOTA
  • 醫療器材(en)
  • NEWS
  • INVESTORS
    • Corporate Governance
      • GOVERNANCE STRUCTURE
      • CORPORATE GOVERNANCE OFFICER
      • BOARD OF DIRECTORS
      • Major Internal Policies
    • Financials
      • MONTHLY REVENUE
      • FINANCIAL REPORTS
    • INVESTOR CONFERENCE
      • INVESTOR CONFERENCE
    • SHAREHOLDERS’ MEETING
      • SHAREHOLDERS’ MEETING
  • ESG
    • SUSTAINABLE MANAGEMENT
      • Message from the Chairman
      • Sustainability Goals and Vision
      • Sustainability Performance
      • Sustainable Management Structure
      • Engagement with Stakeholders and Material Topics Analysis
      • Response to SDGs
    • social inclusion
      • Industry-Academia Collaboration
      • Public Welfare and Donation
      • Actions for Access to Medicines
      • Public participation
      • Supporting Animal Welfare Issues
    • HEALTH CARE
      • Innovative Drugs Research and Development
      • Clinical Trials
      • Drug Safety
      • Supply Chain Management
      • Health Product R&D and Safety
      • Food Quality and Safety
      • Customer Relationship Management
      • Ethical Marketing
    • CORPORATE GOVERNANCE
      • Governance Practices
      • Integrity-Based Operation
      • Internal Audit
      • Risk Management
      • Regulatory Compliance
      • Cyber Security
      • Intellectual Property Rights Protection
    • Safe workplace
      • Trustworthy Employer
      • Talent Development and Cultivation
      • Compensation and Benefits
      • Labor Rights
      • Healthy and Safe Working Environment
    • ENVIRONMENTAL PROTECTION
      • Climate Actions
      • Usage of Water Resources
      • Waste Management
      • Environmental Management
    • ESG DATABASE
      • Policy Statements and Management System Certificates
      • ESG Report
    • INTERACTION ZONE
      • STAKEHOLDER SURVEY
      • SUSTAINABILITY REPORT SURVEY
  • CAREERS
    • CHOOSE MICROBIO
    • COMPENSATION & BENEFITS
    • JOIN MICROBIO
    • LEARNING DEVELOPMENT
MENUMENU
MENUMENU
  • ABOUT US
    • ABOUT
    • CORE VALUE
    • COMPANY STRATEGY
    • ESTABLISHMENT HISTORY
    • CORPORATE LOGO
    • 經營團隊en
    • GOVERNANCE STRUCTURE
  • R & D
    • new drug development
    • new drug development
      • MS-20
      • herbiron
      • ACADEMIC ARTICLE
    • MS-20 Zone
      • PRODUCT INFORMATION
      • RETAIL CHAIN
      • CLINICAL EFFICACY
      • FAQ
      • CONTACT US
    • Health Education Area
      • MS-20 (Health Education Area )
      • HERBIRON (HEALTH EDUCATION AREA )
  • SYMBIOTA
  • 醫療器材(en)
  • NEWS
  • INVESTORS
    • Corporate Governance
      • GOVERNANCE STRUCTURE
      • CORPORATE GOVERNANCE OFFICER
      • BOARD OF DIRECTORS
      • Major Internal Policies
    • Financials
      • MONTHLY REVENUE
      • FINANCIAL REPORTS
    • INVESTOR CONFERENCE
      • INVESTOR CONFERENCE
    • SHAREHOLDERS’ MEETING
      • SHAREHOLDERS’ MEETING
  • ESG
    • SUSTAINABLE MANAGEMENT
      • Message from the Chairman
      • Sustainability Goals and Vision
      • Sustainability Performance
      • Sustainable Management Structure
      • Engagement with Stakeholders and Material Topics Analysis
      • Response to SDGs
    • social inclusion
      • Industry-Academia Collaboration
      • Public Welfare and Donation
      • Actions for Access to Medicines
      • Public participation
      • Supporting Animal Welfare Issues
    • HEALTH CARE
      • Innovative Drugs Research and Development
      • Clinical Trials
      • Drug Safety
      • Supply Chain Management
      • Health Product R&D and Safety
      • Food Quality and Safety
      • Customer Relationship Management
      • Ethical Marketing
    • CORPORATE GOVERNANCE
      • Governance Practices
      • Integrity-Based Operation
      • Internal Audit
      • Risk Management
      • Regulatory Compliance
      • Cyber Security
      • Intellectual Property Rights Protection
    • Safe workplace
      • Trustworthy Employer
      • Talent Development and Cultivation
      • Compensation and Benefits
      • Labor Rights
      • Healthy and Safe Working Environment
    • ENVIRONMENTAL PROTECTION
      • Climate Actions
      • Usage of Water Resources
      • Waste Management
      • Environmental Management
    • ESG DATABASE
      • Policy Statements and Management System Certificates
      • ESG Report
    • INTERACTION ZONE
      • STAKEHOLDER SURVEY
      • SUSTAINABILITY REPORT SURVEY
  • CAREERS
    • CHOOSE MICROBIO
    • COMPENSATION & BENEFITS
    • JOIN MICROBIO
    • LEARNING DEVELOPMENT

herbiron, 英文, 衛教專區(英文)2024 年 8 月 23 日

Abstract

Abstract A safety evaluation was performed of Symbiota®, which is made by a proprietary anaerobic fermentation process of soybean with multistrains of probiotics and a yeast. The battery of genotoxici

15
Read More
news-3
News2024 年 7 月 31 日

The finding on MS-20 combined with anti-PD1 antibody enhancing the cancer treatment response was accepted for publication by Gut Microbes(2023 IF: 12.2).

The finding on MS-20 combined with anti-PD1 antibody enhancing the cancer treatment response was accepted for publication by Gut Microbes(2023 IF: 12.2).

7
Read More
news-3
News2024 年 7 月 22 日

Symbiota exclusively developed by Microbio Co., Ltd. achieves an Independent/Self-affirmed GRAS conclusion according to the U.S. FDA regulations.

Symbiota exclusively developed by Microbio Co., Ltd. achieves an Independent/Self-affirmed GRAS conclusion according to the U.S. FDA regulations.

8
Read More
news-3
News2024 年 7 月 21 日

Microbio (Shanghai) and Oneness have entered into an exclusive agreement of Fespixon commercialization with China Resources Double Crane Pharmaceutical Co., Ltd.

Microbio (Shanghai) and Oneness have entered into an exclusive agreement of Fespixon commercialization with China Resources Double Crane Pharmaceutical Co., Ltd.

7
Read More
news-3
News2024 年 7 月 19 日

Announces the information about the 1st online investor’s conference of 2024.

Announces the information about the 1st online investor’s conference of 2024.

4
Read More
news-3
News2024 年 7 月 15 日

Microbio Co., Ltd. receives a U.S. patent on the new drug MS-20 (CHEMO YOUNG).

Microbio Co., Ltd. receives a U.S. patent on the new drug MS-20 (CHEMO YOUNG).

8
Read More
news-3
News2024 年 6 月 11 日

Annouce the change of the general manager.

Annouce the change of the general manager.

7
Read More
news-3
News2024 年 5 月 30 日

To announce the list of BOD members newly elected at the 2024 Annual Shareholders’Meeting.

To announce the list of BOD members newly elected at the 2024 Annual Shareholders’Meeting.

7
Read More
news-3
News2024 年 5 月 30 日

To announce the election of the chairperson of the board of directors.

To announce the election of the chairperson of the board of directors.

6
Read More
news-3
News2024 年 5 月 30 日

To announce the list of election of the audit committee

To announce the list of election of the audit committee

9
Read More
1 2 3 … 18
Address: 14F-1, No. 3-1, Yuanqu St., Nangang Dist., Taipei City 115603, Taiwan (R.O.C.)
TEL: 02-2655-8558
FAX: 02-2655-8559
  • Facebook
  • YouTube
版權所有 © 中天生物科技股份有限公司. All Rights Reserved.
Copyright © Microbio Co., Ltd. All Rights Reserved.
隱私權條款 | 使用者條款
privacy policy | Terms of service

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.